Cargando…

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms

INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. METHODS: Considering the study objectives, a questionnaire was designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaeimanesh, Nasim, Sahraian, Mohammad Ali, Naser Moghadasi, Abdorreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Neuroscience Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368102/
https://www.ncbi.nlm.nih.gov/pubmed/32855779
http://dx.doi.org/10.32598/bcn.11.covid19.2520.1
_version_ 1783560548103749632
author Rezaeimanesh, Nasim
Sahraian, Mohammad Ali
Naser Moghadasi, Abdorreza
author_facet Rezaeimanesh, Nasim
Sahraian, Mohammad Ali
Naser Moghadasi, Abdorreza
author_sort Rezaeimanesh, Nasim
collection PubMed
description INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. METHODS: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week. RESULTS: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%). CONCLUSION: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself.
format Online
Article
Text
id pubmed-7368102
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Iranian Neuroscience Society
record_format MEDLINE/PubMed
spelling pubmed-73681022020-08-26 Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms Rezaeimanesh, Nasim Sahraian, Mohammad Ali Naser Moghadasi, Abdorreza Basic Clin Neurosci Research Paper INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. METHODS: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week. RESULTS: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%). CONCLUSION: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself. Iranian Neuroscience Society 2020 2020-04-20 /pmc/articles/PMC7368102/ /pubmed/32855779 http://dx.doi.org/10.32598/bcn.11.covid19.2520.1 Text en Copyright© 2020 Iranian Neuroscience Society http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Research Paper
Rezaeimanesh, Nasim
Sahraian, Mohammad Ali
Naser Moghadasi, Abdorreza
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
title Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
title_full Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
title_fullStr Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
title_full_unstemmed Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
title_short Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
title_sort evaluation of the opinion of patients with multiple sclerosis on the outcomes of catching covid-19 and its effects on the ms symptoms
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368102/
https://www.ncbi.nlm.nih.gov/pubmed/32855779
http://dx.doi.org/10.32598/bcn.11.covid19.2520.1
work_keys_str_mv AT rezaeimaneshnasim evaluationoftheopinionofpatientswithmultiplesclerosisontheoutcomesofcatchingcovid19anditseffectsonthemssymptoms
AT sahraianmohammadali evaluationoftheopinionofpatientswithmultiplesclerosisontheoutcomesofcatchingcovid19anditseffectsonthemssymptoms
AT nasermoghadasiabdorreza evaluationoftheopinionofpatientswithmultiplesclerosisontheoutcomesofcatchingcovid19anditseffectsonthemssymptoms